Technol Cancer Res Treat August 2022 PMID 36000314

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast.

Hongyi Zhang, Shasha Tang, Ewelina Biskup, Yi Zhang, Liyun Yong, Lijun Chen, Fengfeng Cai

Full text PDF Download social card

Mentions

Peak: 1 in Aug 2022

across 2 sources since Aug 2022

Extended reach

2,150

potential audience

Total likes

Video views

384

Mentions per month

Aug 2022 – Oct 2024

Where it's discussed

YouTube2 videos
X / Twitter1 posts

AI synopsis

What people are saying

Several discussions reflect an understanding of the research's implications, with posts mentioning the survival outcomes related to different treatments, such as radiotherapy and mastectomy, and recognizing the importance of tumor factors like size and grade. The tone is informational, with some posts noting the potential for the study to influence clinical decisions, demonstrating a balanced and mildly engaged stance.

AgreementModerate agreement

Most discussions acknowledge the significance of the research, with some emphasizing the importance of combining therapies and surgical options.

InterestModerate interest

Participants show moderate interest, often highlighting new findings or interpretative aspects of the study rather than expressing strong enthusiasm.

EngagementModerate engagement

Comments include references to the research methods and implications, indicating a participatory and thoughtful engagement.

ImpactModerate impact

The posts suggest that the publication influences ongoing discussions about treatment approaches for malignant phyllodes tumors, although the overall impact appears moderate.

Abstract in brief

This study examined how different treatments, including radiotherapy (RT), chemotherapy (CT), and surgical options like mastectomy versus breast-conserving surgery (BCS), affect the long-term survival of patients with malignant phyllodes tumors of the breast (MPTB).
The results showed that combining RT and CT actually decreased survival rates, and mastectomy generally led to better overall and cancer-specific survival compared to BCS, especially for early-stage tumors smaller than 50 mm, where RT provided some early survival benefits.
Factors like tumor grade, metastasis, and lymph node involvement significantly influenced survival outcomes, while RT and CT alone did not markedly improve long-term survival for these patients.]

Read the full abstract

All mentions

Understanding Phylloidestumors of the Breast and Latest Treatments

Discover key insights into breast phylloidestumors, including symptoms, diagnosis, and current treatment options. Learn about recent research, holistic approaches, and support resources for patients and families dealing…

Vital Aging Lab · Oct 27, 2024 273 views

Understanding Phyllodes Tumors of the Breast and Treatment Advances

Discover important insights about phyllodes tumors of the breast in our comprehensive guide. From symptoms to diagnosis and the latest treatment methods, we provide expert knowledge.

Vital Aging World · Sep 13, 2024 111 views

Technology in Cancer Research & Treatment journal

@TCRT_Cancer · X

New research from TCRT_Cancer Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast https://t.co/r5MUGYzpt4 #cancerresearch #SAGEresearch #openaccess

Aug 25, 2022 · 1,766 followers View post →